Image

Exercise Testing in ICU Survivors to Evaluate ICU-acquired Weakness

Exercise Testing in ICU Survivors to Evaluate ICU-acquired Weakness

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This study aims to investigate how sepsis and shock can impair microcirculation in intensive care unit (ICU) patients, which can lead to long-lasting muscle weakness/dysfunction or ICU-Acquired Weakness (ICU-AW) and exercise limitations.

Description

This longitudinal study will assess microvascular function through four (4) follow-ups after ICU discharge: at (i) 7 days, (ii) 3 months, (iii) 6 months, and (iv) 12 months. The goal is to understand how microvascular dysfunction contributes to ICU-AW and long-term exercise limitation in ICU survivors.

Specific goals are:

  1. Characterize the natural trajectory of skeletal muscle microvascular function in ICU survivors using high-resolution NIRS.
  2. Demonstrate an impairment in skeletal muscle microvascular oxygen delivery and cardiovascular blood flow regulation in ICU survivors.

Eligibility

Inclusion Criteria:

  • Patients who have received mechanical ventilation for at least 7 days in the MICU or SICU and have subsequently been discharged.
  • Patients enrolled in existing microvascular monitoring study in the ICU regardless of duration of mechanical ventilation.

Exclusion Criteria:

  • Unable to provide consent
  • Trajectory of health expected to be significantly limited in the upcoming 12 months

Study details
    ICU Acquired Weakness
    Microvascular Dysfunction
    Sepsis
    Shock

NCT06193980

University of Manitoba

13 February 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.